Cerebrovascular reactivity over time-course - From major depressive episode to remission

Journal of Psychiatric Research

Volumn 44, Issue 3, 2010, Pages 132-136

  Lemke, Harald ^a   Castro, Ana Gómez Carrillo de ^a   Schlattmann, Peter ^a   Heuser, Isabella ^a   Neu, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cerebral blood flow; Depression; Risk of stroke

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT;

ACETAZOLAMIDE; ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 77649340796     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.06.010     Document Type: Article

References (29)

1. Bjelland I., Grethe S.T., Stein E.V., Refsum H., Ueland P.M. Folate, vitamin B12, homocystein and the MTHFR 677C-T polymorphism in anxiety and depression. Archives of General Psychiatry 2003, 60:618-626.
2. Bottiglieri T., Laundy M., Crellin R., Toone B.K., Carney M.W., Reynolds E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. Journal of Neurology, Neurosurgery and Psychiatry 2000, 69(2):228-232.
3. Broadley A.J., Korszun A., Abdelaal E., Moskvina V., Jones C.J.H., Nash G.B., et al. Inhibition of cortisol production with metyrapone prevents mental stress-induced endothelial dysfunction and baroreflex impairment. Journal of the American College of Cardiology 2005, 46(2):344-350.
4. Chrapko W., Jurasz P., Radomski M.W., Archer S.L., Newman S.C., Baker G., et al. Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology 2006, 31(6):1286-1293.
5. Csépány T., Valikovics A., Fülesdi B., Kiss E., Szegedi G.Y., Csiba L. Transcranial doppler may reveal asymptomatic cerebral vasculopathy in systemic lupus erythematosus. Cerebrovascular Diseases 1995, 5:178-181.
6. Dahl A., Russell D., Rootwelt K., Nyberg-Hansen R., Kerty E. Cerebral vasoreactivity assessed with transcranial doppler and regional cerebral blood flow measurements. Dose, serum concentration, and time course of the response to acetazolamide. Stroke 1995, 26(12):2302-2306.
7. De Chiara S., Mancini M., Vaccaro O. Cerebrovascular reactivity by transcranial doppler-ultrasonography in insulin-dependent diabetic patients. Cerebrovascular Diseases 1993, 3:111-115.
8. Eaton W.W., Armenian H., Gallo J., Pratt L., Ford D.E. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996, 19(10):1097-1102.
9. Faraci F.M., Lentz S.R. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004, 35(2):345-347.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders (SCID I). Administration Booklet 1997, American Press, Washington, DC.
11. Fülesdi B., Limburg M., Bereczki D., Káplár M., Molnár C., Kappelmayer J., et al. Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus. Journal of Diabetes and its Complications 1999, 13(4):191-199.
12. Gómez-Carrillo de Castro A., Bajbouj M., Schlattmann P., Lemke H., Heuser I., Neu P. Cerebrovascular reactivity in depressed patients without vascular risk factors. Journal of Psychiatric Research 2008, 42(1):78-82.
13. Hamilton M. Rating depressive patients. The Journal of Clinical Psychiatry 1980, 41(12Pt 2):21-24.
14. Jonas B.S., Mussolino M.E. Symptoms of depression as a prospective risk factor for stroke. Psychosomatic Medicine 2000, 62(4):463-471.
15. Larson S.L., Owens P.L., Ford D., Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 2001, 32(9):1979-1983.
16. Molina C., Sabín J.A., Montaner J., Rovira A., Abilleirra S., Codina A. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: a case-control study. Stroke 1999, 30(11):2296-2301.
17. Neu P., Schlattmann P., Schilling A., Hartmann A. Cerebrovascular reactivity in major depression: a pilot-study. Psychosomatic Medicine 2004, 66(1):6-8.
18. Neu P., Schwertfeger N., Schlattmann P., Heuser I., Berman R.M. Cerebrovascular reactivity following administration of mirtazapine in healthy probands - a randomized, placebo controlled double-blind clinical study. Journal of Psychiatric Research 2006, 40(4):349-352.
19. Ohira T., Iso H., Satoh S., Sankai T., Tanigawa T., Ogawa Y., et al. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 2001, 32(4):903-908.
20. Rajagopalan S., Brook R., Rubenfire M., Pitt E., Young E., Pitt B. Abnormal brachial artery flow-mediated vasodilatation in young adults with major depression. The American Journal of Cardiology 2001, 88(2):196-198. (Erratum in: The American Journal of Cardiology 2001;88(6):722).
21. Salaycik K.J., Kelly-Hayes M., Beiser A., Nguyen A.-H., Brady S.M., Kase C.S., et al. Depressive symptoms and risk of stroke: the Framingham study. Stroke 2007, 38(1):16-21.
22. Sándor P. Nervous control of the cerebrovascular system: doubts and facts. Neurochemistry International 1999, 35(3):237-259.
23. Settakis G., Molnár C., Kerényi L., Kollár J., Legemate D., Csiba L., et al. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. European Journal of Neurology 2003, 10(6):609-620.
24. Silvestrini M., Troisi E., Matteis M., Cupini L.M., Caltagirone C. Transcranial doppler assessment of cerebrovascular reactivity in symptomatic and asymptomatic severe carotid stenosis. Stroke 1996, 27:1970-1973.
25. Simonsick E.M., Wallace R.B., Blazer D.G., Berkman L.F. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosomatic Medicine 1995, 57(5):427-435.
26. Sterzer P., Meintzschel F., Rösler A., Lanfermann H., Steinmetz H., Sitzer M. Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke 2001, 32(12):2817-2820.
27. Troisi E., Attanasio A., Matteis M., Bragoni M., Monaldo B.C., Caltagirone C., et al. Cerebral hemodynamics in young hypertensive subjects and effects of atenolol treatment. Journal of the Neurological Sciences 1998, 159(1):115-119.
28. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. European Heart Journal 1997, 18(Suppl. E):E19-E29.
29. Yonas H., Smith H.A., Durham S.R., Pentheny S.L., Johnson D.W. Increased stroke risk predicted by compromised cerebral blood flow reactivity. Journal of Neurosurgery 1993, 79:483-489.